Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

NCT07286058 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1182

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: Zasocitinib

Sponsor

Takeda